Neurogene's top three insider shareholders as of March 23, 2026 are Jonathan G Drachman (President And Ceo, 2.37Mn shares), Biocapital Gp, Llc Samsara (TenPercentOwner, 1.72Mn shares), Bros. Advisors Lp Baker (Director, 1.66Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Jonathan G Drachman | President And Ceo | 2,348,686 | 25,000 | 26 Aug, 2021 |
| Biocapital Gp, Llc Samsara | 0 | 1,717,127 | 27 Nov, 2024 | |
| Bros. Advisors Lp Baker | 0 | 1,658,190 | 10 Oct, 2023 | |
| Carl Walkey | Senior Vice President | 1,352,489 | 0 | 17 Jun, 2021 |
| Rachel Mcminn | Chief Executive Officer | 1,347,659 | 0 | 24 Feb, 2026 |
| Christine Mikail Cvijic | President And Cfo | 109,843 | 0 | 03 Mar, 2026 |
| Christine Mikail Cvijic | President And Cfo | 105,798 | 0 | 17 Mar, 2026 |
| Priti Patel | 37,313 | 0 | 04 Apr, 2023 | |
| Stuart Cobb | Chief Scientific Officer | 37,294 | 0 | 24 Feb, 2026 |
| Stuart Cobb | Chief Scientific Officer | 30,497 | 0 | 17 Mar, 2026 |
| Sean Michael Smith | Interim Cfo, Prin Acct Off | 21,637 | 0 | 14 Aug, 2023 |
| Julie Jordan | Chief Medical Officer | 13,300 | 0 | 24 Feb, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 13 Mar, 2026 | Stuart Cobb | Common Stock | D | 3,991 | $20.41 | 33,303 | D | S |
| 13 Mar, 2026 | Christine Mikail Cvijic | Common Stock | D | 2,387 | $20.42 | 107,456 | D | S |
| 13 Mar, 2026 | Christine Mikail Cvijic | Common Stock | D | 1,395 | $21.25 | 106,061 | D | S |
| 13 Mar, 2026 | Stuart Cobb | Common Stock | D | 2,658 | $21.34 | 30,645 | D | S |
| 13 Mar, 2026 | Christine Mikail Cvijic | Common Stock | D | 263 | $22.02 | 105,798 | D | S |
| 13 Mar, 2026 | Stuart Cobb | Common Stock | D | 148 | $22.08 | 30,497 | D | S |
| 27 Feb, 2026 | Christine Mikail Cvijic | Common Stock | D | 4,800 | $25.11 | 109,843 | D | S |
| 27 Feb, 2026 | Christine Mikail Cvijic | Common Stock | D | 4,800 | $25.11 | 109,843 | D | S |
| 20 Feb, 2026 | Sarah B. Noonberg | Non-Qualified Stock Option (right to buy) | A | 12,050 | $0.00 | 12,050 | D | A |
| 20 Feb, 2026 | Rohan Palekar | Non-Qualified Stock Option (right to buy) | A | 12,050 | $0.00 | 12,050 | D | A |
| 20 Feb, 2026 | Christine Mikail Cvijic | Common Stock | A | 22,000 | $0.00 | 114,643 | D | A |
| 20 Feb, 2026 | Christine Mikail Cvijic | Common Stock | A | 22,000 | $0.00 | 114,643 | D | A |
| 20 Feb, 2026 | Robert Baffi | Non-Qualified Stock Option (right to buy) | A | 12,050 | $0.00 | 12,050 | D | A |
| 20 Feb, 2026 | Rachel Mcminn | Common Stock | A | 25,900 | $0.00 | 1,347,659 | D | A |
| 20 Feb, 2026 | Stuart Cobb | Common Stock | A | 16,500 | $0.00 | 37,294 | D | A |
| 20 Feb, 2026 | Cory S. Freedland | Non-Qualified Stock Option (right to buy) | A | 12,050 | $0.00 | 12,050 | D | A |
| 20 Feb, 2026 | Keith Woods | Non-Qualified Stock Option (right to buy) | A | 12,050 | $0.00 | 12,050 | D | A |
| 20 Feb, 2026 | Julie Jordan | Common Stock | A | 4,900 | $0.00 | 13,300 | D | A |
| 20 Feb, 2026 | Stuart Cobb | Common Stock | A | 16,500 | $0.00 | 37,294 | D | A |
| 20 Feb, 2026 | Julie Jordan | Stock Option (Right to Buy) | A | 29,600 | $0.00 | 29,600 | D | A |